Recombinant humanized anti-HER2 antibody (Herceptin (TM)) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts (vol 58, pg 2825, 1998)

Authors
Baselga, J Norton, L Albanell, J Kim, YM Mendelsohn, J
Citation
J. Baselga et al., Recombinant humanized anti-HER2 antibody (Herceptin (TM)) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts (vol 58, pg 2825, 1998), CANCER RES, 59(8), 1999, pp. 2020-2020
Citations number
1
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
8
Year of publication
1999
Pages
2020 - 2020
Database
ISI
SICI code
0008-5472(19990415)59:8<2020:RHAA((>2.0.ZU;2-5